Toll-like receptor 7 and Toll-like receptor 9 agonists effectively enhance immunological memory in Plasmodium chabaudi infected BALB/c mice

被引：3
|
作者：
Gao, Wenyan [1 ,2 ]
Sun, Xiaodan [1 ]
Li, Danni [1 ]
Sun, Lin [1 ]
He, Yang [1 ]
Wei, Huanping [1 ]
Jin, Feng [3 ]
Cao, Yaming [1 ]
机构：
[1] China Med Univ, Dept Immunol, Basic Med Coll, Shenyang 110122, Liaoning, Peoples R China
[2] China Med Univ, Dept Obstet, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
[3] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2020年 / 81卷
基金：
中国国家自然科学基金;
关键词：
PROTECTIVE IMMUNITY; CELL RESPONSES; B-CELLS; DIFFERENTIATION; FALCIPARUM; VACCINES; MALARIA; IMMUNOGENICITY; ADJUVANTS; ANTIBODY;
D O I：
10.1016/j.intimp.2020.106248
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：8
相关论文
共 50 条
  • [11] Toll-like receptors involved in the response to microbial pathogens: Development of agonists for toll-like receptor 9
    Schetter, C
    Vollmer, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (02) : 204 - 210
  • [12] Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists
    Kandimalla, Ekambar R.
    Struthers, Mary
    Bett, Andrew J.
    Wisniewski, Thomas
    Dubey, Sheri A.
    Jiang, Weiwen
    Precopio, Melissa
    Sun, Zhenhua
    Wang, Hao
    Lan, Tao
    Agrawal, Sudhir
    Casimiro, Danilo R.
    CELLULAR IMMUNOLOGY, 2011, 270 (02) : 126 - 134
  • [13] A protective role for toll-like receptor 3 but not toll-like receptor 7 in intimal hyperplasia
    Cole, J.
    Navin, T.
    Cross, A.
    Goddard, M.
    Alexopoulou, L.
    Ucci, S.
    Sivagurunathan, B.
    Davies, A.
    Flavell, R.
    Feldmann, M.
    Monaco, C.
    IMMUNOLOGY, 2011, 135 : 106 - 106
  • [14] Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
    Chatterjee, Piyali
    Weaver, Laura E.
    Doersch, Karen M.
    Kopriva, Shelley E.
    Chiasson, Valorie L.
    Allen, Samantha J.
    Narayanan, Ajay M.
    Young, Kristina J.
    Jones, Kathleen A.
    Kuehl, Thomas J.
    Mitchell, Brett M.
    PLOS ONE, 2012, 7 (07):
  • [15] Clinical setbacks for toll-like receptor 9 agonists in cancer
    Schmidt, Charlie
    NATURE BIOTECHNOLOGY, 2007, 25 (08) : 825 - 826
  • [16] Clinical setbacks for toll-like receptor 9 agonists in cancer
    Charlie Schmidt
    Nature Biotechnology, 2007, 25 : 825 - 826
  • [17] Clinical development of Toll-like receptor-9 agonists
    Schetter, Christian
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (01): : 75 - 75
  • [18] Toll-Like Receptor Agonists Are They Good Adjuvants?
    Gnjatic, Sacha
    Sawhney, Nikhil B.
    Bhardwaj, Nina
    CANCER JOURNAL, 2010, 16 (04): : 382 - 391
  • [19] Toll-like receptor agonists in cancer therapy
    Adams, Sylvia
    IMMUNOTHERAPY, 2009, 1 (06) : 949 - 964
  • [20] Clinical investigations of Toll-like receptor agonists
    Meyer, Thomas
    Stockfleth, Eggert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (07) : 1051 - 1065
12345